As of Jan 17, 2025, DexCom, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $9.7. This suggests it may be overvalued by (88.5%) compared to its current price of around $84.4, using a WACC of 9.3% and growth rates of 3.0%.
As of Jan 17, 2025, DexCom, Inc.'s Weighted Average Cost of Capital (WACC) is approximately 9.3%.
As of Jan 17, 2025, DexCom, Inc.'s Enterprise Value (EV) is approximately $3,685.3M. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.